Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

Melinda L. Telli, Andrea L. Richardson, Bryan T. Hennessy et al.|Clinical Cancer Research|2016

Cited by 1.2k